×
About 162 results
ADYNOVATE®
http://adynovatepro.com

The official ADYNOVATE site for healthcare professionals.

ADVATE® [Antihemophilic Factor (Recombinant)]
http://advatepro.com/

The myPKFiT software is intended for use by licensed healthcare professionals (HCPs) who are familiar with hemophilia care. The myPKFiT software can be used to generate ADVATE dosage amount and frequency recommendations for routine prophylaxis for an individual patient 16 years of age and older and body ...

AFSTYLA [Antihemophilic Factor (Recombinant), Single Chain]
http://afstyla.com/hcp

Learn about AFSTYLA, recombinant FVIII therapy that delivers long-lasting bleed protection for patients with hemophilia A. Explore how to sign up your patients for a free 30-day trial.

ELOCTATE® (antihemophilic factor (recombinant), Fc fusion protein)
https://www.eloctatepro.com/

Information for healthcare providers about ELOCTATE® [Antihemophilic factor (recombinant), Fc fusion protein].

FEIBA (anti-inhibitor coagulant complex) INTRAVENOUS
https://www.feiba.com/us/hcp/

The official HCP site for FEIBA. Please see Detailed Important Risk Information including BOXED WARNING and full Prescribing Information.

IXINITY® (Coagulation Factor IX (Recombinant)) LYOPHILIZED POWDER FOR SOLUTION FOR INTRAVENOUS INJECTION
http://hcp.ixinity.com/

IXINITY® is a recombinant factor IX hemophilia B treatment option. Healthcare professionals, get IXINITY savings, dosage, and clinical information.

KOGENATE FS ANTIHEMOPHILIC FACTOR (recombinant)
https://www.kogenatefs.com/

Official site from Bayer. Learn about Kogenate® FS, Antihemophilic Factor (Recombinant), including uses, safety and administration information.

KOVALTRY ANTIHEMOPHILIC FACTOR (recombinant)
https://www.kovaltryhcp.com/

KOVALTRY®, Antihemophilic Factor (Recombinant), is the only unmodified, full-length rFVIII. Please see full Important Safety Information.

Rebinyn® (Coagulation Factor IX [Recombinant], GlycoPEGylated)
https://www.rebinynpro.com/

HCP site for Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated, a treatment for hemophilia from Novo Nordisk. Read Important Safety ...

OBIZUR [Antihemophilic Factor (Recombinant), Porcine Sequence]
http://www.obizur.com/baxalta-hemophilia.html

Learn more about OBIZUR [Antihemophilic Factor (Recombinant), Porcine Sequence], a recombinant porcine sequence factor.

IDELVION® (coagulation factor IX (recombinant), albumin fusion protein (rFIX-FP)) LYOPHILIZED POWDER FOR SOLUTION FOR INTRAVENOUS INJECTION
http://www.idelvion.com/hcp

IDELVION is the only treatment for hemophilia B with 14 - day dosing. With 7- and 14- day dosing regimens, give your patients greater freedom from infusions.

NOVOEIGHT® Antihemophilic Factor (Recombinant)
https://www.novoeightpro.com/

Novoeight® (Antihemophilic Factor [Recombinant]) is indicated for use in adults and children with hemophilia A for control and prevention of bleeding, among other indications. See Prescribing Info.

NOVOSEVEN® RT Coagulation Factor VIIa (Recombinant)
https://www.novosevenrtpro.com/

Use our convenient dosing calculator. With our dosing calculator, you can quickly determine the recommended NovoSeven® RT dose for your patient, plus the number of vials required.

ALPHANATE® (antihemophilic factor/VWF complex [human])
http://alphanate.com/en/hcp

FVIII/VWF complex. ... ALPHANATE is the only FVIII/VWF complex to offer the convenience of a large 2000-IU vial size with low diluent volume. ... The ALPHANATE manufacturing process includes 10 steps to safety, with full traceability from donor to patient.

BENEFIX® FOR HEMOPHILIA B RECOMBINANT (coagulation Factor IX (Recombinant))
https://www1.pfizerpro.com/product/benefix/hemophilia-b

Find more information, including benefits and risks about Pfizer Hemophilia's factor IX therapy for your hemophilia B patients.

XYNTHA® (antihemophilic factor [recombinant]) LYOPHILIZED POWDER FOR SOLUTION
https://www1.pfizerpro.com/product/xyntha/hemophilia-a

Allergic-type hypersensitivity reactions, including anaphylaxis, are possible with XYNTHA®. Inform patients of the early signs or symptoms of hypersensitivity reactions (including hives, generalized urticaria, chest tightness, wheezing, and hypotension) and anaphylaxis.

HEMOFIL M Antihemophilic Factor (Human),
https://www.shirecontent.com/PI/PDFs/HEMOFILM_USA_ENG.pdf

HEMOFIL M is indicated in hemophilia A (classical hemophilia) for the prevention and control of hemorrhagic episodes.

RECOMBINATE Antihemophilic Factor (Recombinant) Prescribing Information
https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM200909.pdf

The use of RECOMBINATE [Antihemophilic Factor (Recombinant)] is indicated in hemophilia A (classical hemophilia) for the prevention and control of hemorrhagic episodes.2 RECOMBINATE is also indicated in the perioperative management of patients with hemophilia A (classical hemophilia).

RIXUBIS [Coagulation Factor IX (Recombinant)]
https://www.rixubis.com/hcp-efficacy-and-safety/

Please see Detailed Important Risk Information and Full Prescribing Information.